SUMMARY Systolic anterior motion (SAM) of the mitral valve in the absence of asymmetric septal hypertrophy or concentric left ventricular hypertrophy has been reported in several conditions. In this report we describe the clinical and echocardiographic findings in 15 patients who demonstrated SAM without associated organic heart disease (group 1, 10 patients) or in association with mitral valve prolapse (group 2, five patients). Cross-sectional echocardiography revealed the etiology of SAM in both groups to be early systolic anterior angular motion ("buckling") of mitral chordal structures, rather than movement of the body of the anterior mitral leaflet into the left ventricular outflow tract. In contrast to normal subjects and group 1, group 2 patients had auscultatory evidence of mitral prolapse, a slightly greater mean left ventricular ejection fraction (p < 0.05) (normals, 69 ± 5.2%, group 1, 72 ± 3.8%, group 2, 75 ± 5.6%), and a greater mean diastolic mitral valve (D-E) excursion (p < 0.05) (normals, 1.8 ± 0.2 cm, group 1, 2.2 ± 0.3 cm, and group 2, 2.6 ± 0.4 cm). This spectrum of mitral excursion and left ventricular ejection fraction supports the concept that the mitral valve prolapse syndrome may have as its basis a mitral valve abnormality and/or a hyperdynamic state that predispose to both chordal buckling and mitral leaflet prolapse.
SYSTOLIC ANTERIOR MOTION (SAM) of the mitral valve was initially described in conjunction with asymmetric septal hypertrophy as one of the two echocardiographic hallmarks of idiopathic hypertrophic subaortic stenosis or hypertrophic obstructive cardiomyopathy.'~' The presence of SAM was considered to be the M-mode echocardiographic manifestation of the left ventricular outflow obstruction in hypertrophic cardiomyopathy.' ' Furthermore, the amount of SAM (i.e., the degree and duration of the approximation of the anterior mitral leaflet to the ventricular septum) was reported to correlate with the presence and the degree of left ventricular outflow obstruction.4 More recently, SAM has been reported without asymmetric septal hypertrophy both in the presence"8 and in the absenceg of associated subaortic obstruction. Conditions other than hypertrophic cardiomyopathy known to be associated with SAM include membranous subaortic stenosis,10 dextraposition of the great vessels with subpulmonic obstruction,1' pulmonary hypertension,'2 concentric left ventricular hypertrophy, 13 14 hyperkinetic states14' 1 ' (including aortic insufficiency and hypovolemia), mitral valve prolapse (MVP)16-'8 and the absence of detectable heart disease. 8, 15, 19 Fifteen patients who demonstrated SAM in the absence of hypertrophic cardiomyopathy on M-mode echocardiography were studied prospectively. Five of these patients had MVP; the other 10 had no evidence of organic heart disease. This report describes the clinical, phonocardiographic and echocardiographic findings in these 15 patients. Cross-sectional echocardiography defined a mechanism for the production of SAM in this group that differs from the mechanism initially reported in patients with hypertrophic obstructive cardiomyopathy. Figure 2B is a characteristic M-mode echocardiogram of the mitral valve from a group 2 patient. SAM begins early in systole, followed by a late systolic posterior motion (prolapse) behind the C-D line. All group 2 patients had findings of early SAM followed by late systolic MVP. Echocardiographic scans in each patient from the level of the aortic root and left atrium to the lower left ventricle demonstrated that SAM did not, in fact, represent beam-width artifact from the posterior aortic root wall or an artifact related to improper transducer angulation. None of our 15 normal subjects had SAM or MVP.
Materials and Methods

Cross-sectional Echocardiographic Findings
Of the 10 patients in group 1, nine showed definite or probable anterior buckling of mitral subvalvular (chordal) structures (MCB) by cross-sectional echocardiography (table 2). The probable MCB was composed of patients in whom systolic anterior buckling of mitral subvalvular structures was present but could not be visualized during every cardiac cycle. In patients 2, 7 and 9, the mitral chordal junction, including the tip of the anterior mitral leaflet, appeared to be involved in the MCB. Figures 3 and 4 illustrate the phenomenon of MCB in two group 1 patients as visualized with crosssectional echocardiography. These long-axis sequences of systolic and diastolic frames demonstrate an acutely angulated early SAM of mitral subvalvular structures giving rise to the appearance of buckling or kinking. The body of the anterior mitral leaflet moves normally (not toward the septum during systole). Although MCB could also be visualized in short-axis and apical four-chamber views, the long-axis view was the best for imaging this phenomenon.
All five group 2 patients demonstrated MCB, followed by one of the abnormal mitral leaflet coaptation patterns described in MVP.28 Four group 2 patients demonstrated coaptation of the tips of both anterior and posterior mitral leaflets behind (cephalad to) the plane of the mitral annulus, whereas one patient demonstrated prolapse of primarily the anterior mitral leaflet. None of the 15 normal subjects demonstrated either MCB or an abnormal mitral coaptation pattern. Discussion Our data confirm the findings of others that the presence of SAM on the M-mode echocardiogram is not diagnostic of hypertrophic (obstructive) cardiomyopathy, but is seen frequently in other forms of heart disease.'0-"8 Using cross-sectional echocardiography, we demonstrated MCB as the underlying mechanism for SAM in our two groups.
The findings of mitral chordal (and mitral-chordal junction) buckling in our five patients with SAM and MVP is similar to the description of one patient by Terasawa and co-workers,16 who, by cross-sectional echocardiography, noted that SAM was due to protrusion into the left ventricular outflow tract of the slackened chordae tendineae in early systole. When the slackened cordae tendineae were stretched taut in midsystole, the anterior leaflet moved to the position of maximal prolapse. Furthermore, in a recent preliminary report, Pearlman and co-workers have also described buckling of the mitral chordae (often involving the tip of the anterior leaflet as well) as the etiology for SAM in MVP.29 Our findings do not confirm the suggestion of Sahn et al. that the appearance of SAM in mitral valve prolapse is created by superimposition of the mitral annulus and mitral valve leaflet. 18 MCB differs from the SAM of the anterior mitral leaflet into the left ventricular outflow tract initially described for hypertrophic obstructive cardiomyopathy by Henry et al.30 More recently, however, other workers have emphasized other mechanisms for the production of SAM in hypertrophic cardiomyopathy. Rodger3' described SAM as a complex of echoes from the chordae tendineae, the papillary muscle and the anterior mitral leaflet, the latter structure being the furthest from and not impinging upon the septum. In Finally, the finding of a continuum for mitral valve diastolic (D-E) excursion (and perhaps also for left ventricular ejection fraction) from normal subjects to patients with SAM only (group 1), to patients with SAM and MVP (group 2) raises the possibility that there is a spectrum of mitral valve abnormality that may become manifest as MCB alone, MVP alone, or as both conditions. One might postulate that this valvular abnormality might reflect both structural and hemodynamic factors. Mitral valve hooding, thickening, and redundant chordae tendineae (excessive chordal length relative to left ventricular long-axis dimension) have been described at necropsy in patients who had MVP. 33 The association of a hyperadrenergic state with MVP has also been described. 34 Perhaps the predisposition to MCB in our group 1 (SAM without MVP) and group 2 (SAM with MVP) patients reflects the relative redundancy of the chordae tendineae in these patients with or without a superimposed hyperadrenergic state. This hypothesis, however, requires further confirmation. CLINICALLY SIGNIFICANT cardiac amyloidosis accounts for 5-10% of all forms of isolated noncoronary cardiomyopathy.' Although the clinicopathologic findings of such an unusual form of heart disease have been well described,'-" only a few investigators have reported the echocardiographic features of amyloid cardiomyopathy,' 1-3 and their observations and conclusions are based on small numbers of patients. Two-dimensional echocardiography has increased our ability to diagnose several forms of cardiac disease. However, to our knowledge, there have been no reports on two-dimensional echocardiographic features of amyloid heart disease.
The purpose of this retrospective study was to analyze in detail the M-mode echocardiographic features in a relatively large group of patients with systemic amyloidosis, and to describe the two-dimensional echocardiographic features of this disease.
